0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell and Gene Therapy Drug Delivery Devices Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-5T14298
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell and Gene Therapy Drug Delivery Devices Market Research Report 2023
BUY CHAPTERS

Global Cell and Gene Therapy Drug Delivery Devices Market Research Report 2025

Code: QYRE-Auto-5T14298
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell and Gene Therapy Drug Delivery Devices Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cell and Gene Therapy Drug Delivery Devices Market

Cell and Gene Therapy Drug Delivery Devices Market

The global market for Cell and Gene Therapy Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge. Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy. Cell and gene therapies may offer longer-lasting effects than traditional medicines. One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy. Various market players are actively investing in the research and development of the cell and gene therapy industry. The players are offering improved and new products, which meet the critical needs of patients.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Drug Delivery Devices.
The Cell and Gene Therapy Drug Delivery Devices market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell and Gene Therapy Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Drug Delivery Devices companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell and Gene Therapy Drug Delivery Devices Market Report

Report Metric Details
Report Name Cell and Gene Therapy Drug Delivery Devices Market
CAGR 5%
Segment by Type
Segment by Application
  • Luxturna
  • Kymriah
  • Provenge
  • Zolgensma
  • Yescarta
  • Strimvelis
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute, Kite Pharma, Inc., Kolon Tissue Gene, inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell and Gene Therapy Drug Delivery Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell and Gene Therapy Drug Delivery Devices Market report?

Ans: The main players in the Cell and Gene Therapy Drug Delivery Devices Market are Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute, Kite Pharma, Inc., Kolon Tissue Gene, inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation

What are the Application segmentation covered in the Cell and Gene Therapy Drug Delivery Devices Market report?

Ans: The Applications covered in the Cell and Gene Therapy Drug Delivery Devices Market report are Luxturna, Kymriah, Provenge, Zolgensma, Yescarta, Strimvelis

What are the Type segmentation covered in the Cell and Gene Therapy Drug Delivery Devices Market report?

Ans: The Types covered in the Cell and Gene Therapy Drug Delivery Devices Market report are Sterile Insulin Syringe, Pre-Filled Syringe, Infusion Bags

Recommended Reports

Cell & Gene Therapy

Drug Delivery Devices

Therapeutic Innovations

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sterile Insulin Syringe
1.2.3 Pre-Filled Syringe
1.2.4 Infusion Bags
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Luxturna
1.3.3 Kymriah
1.3.4 Provenge
1.3.5 Zolgensma
1.3.6 Yescarta
1.3.7 Strimvelis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Perspective (2020-2031)
2.2 Global Cell and Gene Therapy Drug Delivery Devices Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Region (2020-2025)
2.2.3 Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2026-2031)
2.3 Cell and Gene Therapy Drug Delivery Devices Market Dynamics
2.3.1 Cell and Gene Therapy Drug Delivery Devices Industry Trends
2.3.2 Cell and Gene Therapy Drug Delivery Devices Market Drivers
2.3.3 Cell and Gene Therapy Drug Delivery Devices Market Challenges
2.3.4 Cell and Gene Therapy Drug Delivery Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue (2020-2025)
3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2020-2025)
3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy Drug Delivery Devices Revenue
3.4 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Drug Delivery Devices Revenue in 2024
3.5 Global Key Players of Cell and Gene Therapy Drug Delivery Devices Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Product and Application
3.7 Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Type
4.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Type (2020-2025)
4.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2026-2031)
5 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Application
5.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Application (2020-2025)
5.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size (2020-2031)
6.2 North America Cell and Gene Therapy Drug Delivery Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2020-2025)
6.4 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2020-2031)
7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2020-2025)
7.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size (2020-2031)
9.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2020-2025)
9.4 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen, Inc.
11.1.1 Amgen, Inc. Company Details
11.1.2 Amgen, Inc. Business Overview
11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.1.4 Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.1.5 Amgen, Inc. Recent Development
11.2 Bausch and Lomb Incorporated
11.2.1 Bausch and Lomb Incorporated Company Details
11.2.2 Bausch and Lomb Incorporated Business Overview
11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Introduction
11.2.4 Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.2.5 Bausch and Lomb Incorporated Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Details
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Introduction
11.3.4 Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 Bluebird bio, Inc.
11.4.1 Bluebird bio, Inc. Company Details
11.4.2 Bluebird bio, Inc. Business Overview
11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.4.4 Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.4.5 Bluebird bio, Inc. Recent Development
11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details
11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Introduction
11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Development
11.6 Dendreon Pharmaceuticals LLC.
11.6.1 Dendreon Pharmaceuticals LLC. Company Details
11.6.2 Dendreon Pharmaceuticals LLC. Business Overview
11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Introduction
11.6.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.6.5 Dendreon Pharmaceuticals LLC. Recent Development
11.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details
11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Introduction
11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Development
11.8 Human Stem Cell Institute
11.8.1 Human Stem Cell Institute Company Details
11.8.2 Human Stem Cell Institute Business Overview
11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Introduction
11.8.4 Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.8.5 Human Stem Cell Institute Recent Development
11.9 Kite Pharma, Inc.
11.9.1 Kite Pharma, Inc. Company Details
11.9.2 Kite Pharma, Inc. Business Overview
11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.9.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.9.5 Kite Pharma, Inc. Recent Development
11.10 Kolon Tissue Gene, inc.
11.10.1 Kolon Tissue Gene, inc. Company Details
11.10.2 Kolon Tissue Gene, inc. Business Overview
11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.10.4 Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.10.5 Kolon Tissue Gene, inc. Recent Development
11.11 Novartis AG
11.11.1 Novartis AG Company Details
11.11.2 Novartis AG Business Overview
11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Introduction
11.11.4 Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.11.5 Novartis AG Recent Development
11.12 Orchard Therapeutics plc.
11.12.1 Orchard Therapeutics plc. Company Details
11.12.2 Orchard Therapeutics plc. Business Overview
11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.12.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.12.5 Orchard Therapeutics plc. Recent Development
11.13 Pfizer, Inc.
11.13.1 Pfizer, Inc. Company Details
11.13.2 Pfizer, Inc. Business Overview
11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.13.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.13.5 Pfizer, Inc. Recent Development
11.14 Renova Therapeutics
11.14.1 Renova Therapeutics Company Details
11.14.2 Renova Therapeutics Business Overview
11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Introduction
11.14.4 Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.14.5 Renova Therapeutics Recent Development
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Details
11.15.2 Spark Therapeutics, Inc. Business Overview
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.15.5 Spark Therapeutics, Inc. Recent Development
11.16 uniQure N.V.
11.16.1 uniQure N.V. Company Details
11.16.2 uniQure N.V. Business Overview
11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Introduction
11.16.4 uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.16.5 uniQure N.V. Recent Development
11.17 Vericel Corporation
11.17.1 Vericel Corporation Company Details
11.17.2 Vericel Corporation Business Overview
11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Introduction
11.17.4 Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
11.17.5 Vericel Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Sterile Insulin Syringe
 Table 3. Key Players of Pre-Filled Syringe
 Table 4. Key Players of Infusion Bags
 Table 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2020-2025)
 Table 9. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2026-2031)
 Table 11. Cell and Gene Therapy Drug Delivery Devices Market Trends
 Table 12. Cell and Gene Therapy Drug Delivery Devices Market Drivers
 Table 13. Cell and Gene Therapy Drug Delivery Devices Market Challenges
 Table 14. Cell and Gene Therapy Drug Delivery Devices Market Restraints
 Table 15. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Players (2020-2025)
 Table 17. Global Top Cell and Gene Therapy Drug Delivery Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2024)
 Table 18. Ranking of Global Top Cell and Gene Therapy Drug Delivery Devices Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Headquarters and Area Served
 Table 21. Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Product and Application
 Table 22. Global Key Players of Cell and Gene Therapy Drug Delivery Devices, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2020-2025)
 Table 26. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2026-2031)
 Table 28. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Application (2020-2025)
 Table 30. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Application (2026-2031)
 Table 32. North America Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Amgen, Inc. Company Details
 Table 48. Amgen, Inc. Business Overview
 Table 49. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product
 Table 50. Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 51. Amgen, Inc. Recent Development
 Table 52. Bausch and Lomb Incorporated Company Details
 Table 53. Bausch and Lomb Incorporated Business Overview
 Table 54. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product
 Table 55. Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 56. Bausch and Lomb Incorporated Recent Development
 Table 57. Becton, Dickinson and Company Company Details
 Table 58. Becton, Dickinson and Company Business Overview
 Table 59. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product
 Table 60. Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 61. Becton, Dickinson and Company Recent Development
 Table 62. Bluebird bio, Inc. Company Details
 Table 63. Bluebird bio, Inc. Business Overview
 Table 64. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product
 Table 65. Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 66. Bluebird bio, Inc. Recent Development
 Table 67. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details
 Table 68. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
 Table 69. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product
 Table 70. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 71. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Development
 Table 72. Dendreon Pharmaceuticals LLC. Company Details
 Table 73. Dendreon Pharmaceuticals LLC. Business Overview
 Table 74. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product
 Table 75. Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 76. Dendreon Pharmaceuticals LLC. Recent Development
 Table 77. Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details
 Table 78. Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
 Table 79. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product
 Table 80. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 81. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Development
 Table 82. Human Stem Cell Institute Company Details
 Table 83. Human Stem Cell Institute Business Overview
 Table 84. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product
 Table 85. Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 86. Human Stem Cell Institute Recent Development
 Table 87. Kite Pharma, Inc. Company Details
 Table 88. Kite Pharma, Inc. Business Overview
 Table 89. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product
 Table 90. Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 91. Kite Pharma, Inc. Recent Development
 Table 92. Kolon Tissue Gene, inc. Company Details
 Table 93. Kolon Tissue Gene, inc. Business Overview
 Table 94. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product
 Table 95. Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 96. Kolon Tissue Gene, inc. Recent Development
 Table 97. Novartis AG Company Details
 Table 98. Novartis AG Business Overview
 Table 99. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product
 Table 100. Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 101. Novartis AG Recent Development
 Table 102. Orchard Therapeutics plc. Company Details
 Table 103. Orchard Therapeutics plc. Business Overview
 Table 104. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product
 Table 105. Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 106. Orchard Therapeutics plc. Recent Development
 Table 107. Pfizer, Inc. Company Details
 Table 108. Pfizer, Inc. Business Overview
 Table 109. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product
 Table 110. Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 111. Pfizer, Inc. Recent Development
 Table 112. Renova Therapeutics Company Details
 Table 113. Renova Therapeutics Business Overview
 Table 114. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product
 Table 115. Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 116. Renova Therapeutics Recent Development
 Table 117. Spark Therapeutics, Inc. Company Details
 Table 118. Spark Therapeutics, Inc. Business Overview
 Table 119. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product
 Table 120. Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 121. Spark Therapeutics, Inc. Recent Development
 Table 122. uniQure N.V. Company Details
 Table 123. uniQure N.V. Business Overview
 Table 124. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product
 Table 125. uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 126. uniQure N.V. Recent Development
 Table 127. Vericel Corporation Company Details
 Table 128. Vericel Corporation Business Overview
 Table 129. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product
 Table 130. Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025) & (US$ Million)
 Table 131. Vericel Corporation Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources
 Table 135. Authors List of This Report


List of Figures
 Figure 1. Cell and Gene Therapy Drug Delivery Devices Picture
 Figure 2. Global Cell and Gene Therapy Drug Delivery Devices Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Type: 2024 VS 2031
 Figure 4. Sterile Insulin Syringe Features
 Figure 5. Pre-Filled Syringe Features
 Figure 6. Infusion Bags Features
 Figure 7. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application: 2024 VS 2031
 Figure 9. Luxturna Case Studies
 Figure 10. Kymriah Case Studies
 Figure 11. Provenge Case Studies
 Figure 12. Zolgensma Case Studies
 Figure 13. Yescarta Case Studies
 Figure 14. Strimvelis Case Studies
 Figure 15. Cell and Gene Therapy Drug Delivery Devices Report Years Considered
 Figure 16. Global Cell and Gene Therapy Drug Delivery Devices Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Cell and Gene Therapy Drug Delivery Devices Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Region: 2024 VS 2031
 Figure 19. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Players in 2024
 Figure 20. Global Top Cell and Gene Therapy Drug Delivery Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2024
 Figure 22. North America Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2020-2031)
 Figure 24. United States Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2020-2031)
 Figure 28. Germany Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2020-2031)
 Figure 36. China Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2020-2031)
 Figure 44. Mexico Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2020-2031)
 Figure 48. Turkey Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Amgen, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 52. Bausch and Lomb Incorporated Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 53. Becton, Dickinson and Company Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 54. Bluebird bio, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 55. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 56. Dendreon Pharmaceuticals LLC. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 57. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 58. Human Stem Cell Institute Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 59. Kite Pharma, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 60. Kolon Tissue Gene, inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 61. Novartis AG Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 62. Orchard Therapeutics plc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 63. Pfizer, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 64. Renova Therapeutics Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 65. Spark Therapeutics, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 66. uniQure N.V. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 67. Vericel Corporation Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS